000 00984 a2200241 4500
005 20250516091012.0
264 0 _c20120913
008 201209s 0 0 eng d
022 _a0946-1965
024 7 _a10.5414/CP201701A
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFuhr, Uwe
245 0 0 _aPhenotyping the activity of drug metabolizing enzymes using limited sampling strategies: perturbations and bias.
_h[electronic resource]
260 _bInternational journal of clinical pharmacology and therapeutics
_cJul 2012
300 _a476-7 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aCytochrome P-450 CYP3A
_xphysiology
650 0 4 _aCytochrome P-450 CYP3A Inhibitors
650 0 4 _aHumans
650 0 4 _aMidazolam
_xpharmacokinetics
773 0 _tInternational journal of clinical pharmacology and therapeutics
_gvol. 50
_gno. 7
_gp. 476-7
856 4 0 _uhttps://doi.org/10.5414/CP201701A
_zAvailable from publisher's website
999 _c21739331
_d21739331